About the Journal

Aim and Scope

The International Journal of Pharmaceutical Investigation aims to disseminate high-quality peer-reviewed scientific research and advance knowledge in all areas of Pharmaceutical Sciences, including pharmaceutics, nanotechnology, drug delivery, biopharmaceutics, regulatory sciences and more. International Journal of Pharmaceutical Investigation is a comprehensive resource for both professionals and researchers in the field of pharmaceutical sciences. Its broad focus spans a variety of categories within the field, including pharmaceutical drug delivery, providing the latest in research, reviews, and commentaries on current developments. The journal publishes original research articles, comprehensive review articles, case reports, short communications, letters to the editor, commentaries and editorials on topics of current interest. Manuscripts focusing on pharmaceutical innovation, novel drug delivery approaches, quality management, regulatory pathways, and other emerging areas within the pharmaceutical field are particularly encouraged. The scope of the journal covers both fundamental and applied aspects of disciplines such as pharmaceutics, nanotechnology, biopharmaceutics, pharmacokinetics, industrial pharmacy, pharmacognosy, medicinal chemistry, pharmacology, pharmaceutical regulatory affairs, intellectual property and more. Submissions with clinical, technological, regulatory or practical implications that can further pharmaceutical research and development are also within the scope. Through rigorous peer review and a rapid publication process, the journal aims to effectively disseminate significant scientific findings to researchers, academics and professionals engaged in pharmaceutical sciences and related industries on a global platform.

Founded in 0, the International Journal of Pharmaceutical Investigation publishes quarterly under the editorial direction of Vanaja K. The journal welcomes original research, short communications, forum articles and critical reviews that advance . All submissions undergo single-blind peer review by at least two independent referees, and accepted manuscripts appear in press ahead of issue assignment.

Subject sections